Sanofi (SNY) news

Sanofi India - Gets show cause notice for tax liability of 363.9 mln rupees and penalty of 363.9 mln rupees

Sino Biopharmaceutical - Group eligible for up to $123 mln in milestone payments and tiered double-digit royalties

Sino Biopharmaceutical Limited (SEHK: 2010) has entered into an exclusive global licensing agreement with Sanofi S.A. for rovadicitinib, a first-in-class oral small molecule JAK/ROCK inhibitor. Under the terms of the agreement, Sino Biopharm’s subsidiary, Chia Tai Tianqing Pharmaceutical Group Co.,…

Sino Biopharmaceutical - launches new global brand SBP Group

Sino Biopharmaceutical Limited has announced the launch of its new global brand, SBP Group, marking a strategic shift toward international expansion and reinforcing its commitment to innovation in the pharmaceutical sector. The rebranding reflects the company’s evolution from a domestic…

EMA: Sanofi Winthrop Industrie withdrew its application for use of Dupixent on 24 June 2026

Sanofi Winthrop Industrie has withdrawn its application to expand the use of Dupixent (dupilumab) for the treatment of chronic spontaneous urticaria in adults and adolescents aged 12 years and older, according to the European Medicines Agency (EMA) . The application had sought to extend the…

France's CAC 40 down 0.59%; Spain's IBEX down 0.71%

On August 17, 2026, France's CAC 40 closed down 0.59%, reversing earlier gains and ending a three-week winning streak amid ongoing geopolitical tensions and inflation concerns. The index closed at 8,635 points, with major declines in sectors such as energy and technology. STMicroelectronics, ENGIE,…